Shire Files Suit against Cadila Healthcare Limited doing business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc. Dublin, Ireland and Philadelphia, US - July 8, 2010 - Shire plc (LSE: SHP, ...

Shire Pharmaceuticals Group Licenses The North American Rights For SPD754 (apricitabine) To Avexa Limited In Return For US$10 Million BASINGSTOKE, England and ...

Thank you very much for joining our conference despite your busy schedule. About the translation speaker receiver, channel 1 is English and channel 2 is Japanese. Let me introduce today's presenters.

VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder [1], [2], [3] Shire plc (LSE: SHP, NASDAQ ...

Neptune-based WellSpring Pharmaceutical on Thursday announced the purchase of a pharmaceutical manufacturing plant in Toronto, Canada from Shire Pharmaceuticals Group (Nasdaq: SHPGY) of Basingstoke, ...

Takeda Pharmaceutical Co.’s 2019 acquisition of its larger European rival Shire PLC made it one of the most indebted drugmakers in the world. Four years later, Takeda has not only brought its debt ...

Please provide your email address to receive an email when new articles are posted on . Takeda Pharmaceutical announced it has entered into an agreement to acquire Shire for approximately 46 billion ...

Takeda Pharmaceutical has agreed to buy Shire PLC for $62 billion, successfully ending a takeover battle for the Ireland-based drugmaker and creating a company with leading treatments for rare ...

- Shire Limited ordinary shareholders who acquire their Shire Limited ordinary shares after the Scheme becomes effective, who hold 25,000 or fewer Shire Limited ordinary shares on the first dividend ...

Takeda Pharmaceutical Co.4502-0.26%decrease; red down pointing triangle on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker and marking ...

Consumers have grown used to being told to give up their brand-name drugs in favor of cheaper generics. Now some are finding the opposite is true. By Charles Ornstein and Katie Thomas When ...

Takeda Pharmaceutical Co. is nearing a preliminary agreement to acquire Shire Plc after the Japanese drugmaker sweetened its roughly $60 billion bid for the biotechnology company, according to people ...